Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Dec;64(12):5066–5074. doi: 10.1128/iai.64.12.5066-5074.1996

Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin.

J P Dalton 1, S McGonigle 1, T P Rolph 1, S J Andrews 1
PMCID: PMC174490  PMID: 8945548

Abstract

Two cathepsin L proteinases, cathepsin L1 and cathepsin L2, secreted by liver flukes may be involved in tissue penetration, nutrition, and protection from immune attack. To ascertain the immunoprophylactic potential of these proteinases, and of another molecule, liver fluke hemoglobin (Hb), we performed vaccine trials in cattle. In the first vaccine trial various doses of cathepsin L1 were tested. The mean protection level obtained was 53.7%. In a second vaccine trial cathepsin L1 and Hb elicited 42.5 and 43.8% protection levels, respectively, while a combination of the two molecules induced a significantly higher level of protection (51.9%). Cathepsin L2 was not examined alone; however, vaccination of cattle with a combination of cathepsin L2 and Hb elicited the highest level of protection (72.4%). The animals that received cathepsin L1-Hb or cathepsin L2-Hb showed reduced liver damage as assessed by serum glutamic dehydrogenase and gamma-glutamyl transferase levels. Furthermore, a reduced viability was observed for fluke eggs recovered from all vaccine groups. This anti-embryonation effect of vaccination was particularly evident in the group that received cathepsin L2-Hb where >98% of the eggs recovered did not embryonate to miracidia. Although all vaccine preparations induced high antibody titers which were boosted following the challenge infection, there was no correlation between antibody titers and protection. The results of these trials demonstrate that cathepsin Ls and Hb could form the basis of a molecular vaccine that would not only reduce parasite burden but would also prevent transmission of liver fluke disease.

Full Text

The Full Text of this article is available as a PDF (308.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ajala M. O., Asaolu S. O. Efficiency of the salt flotation technique in the recovery of Ascaris lumbricoides eggs from the soil. J Helminthol. 1995 Mar;69(1):1–5. doi: 10.1017/s0022149x00013754. [DOI] [PubMed] [Google Scholar]
  2. Anderson P. H., Berrett S., Brush P. J., Hebert C. N., Parfitt J. W., Patterson D. S. Biochemical indicators of liver injury in calves with experimental fascioliasis. Vet Rec. 1977 Jan 15;100(3):43–45. doi: 10.1136/vr.100.3.43. [DOI] [PubMed] [Google Scholar]
  3. BJOERKMAN N., THORSELL W. ON THE FINE MORPHOLOGY OF THE FORMATION OF EGG-SHELL GLOBULES IN THE VITELLINE GLANDS OF THE LIVER FLUKE (FASCIOLA HEPATICA, L.). Exp Cell Res. 1963 Oct;32:153–156. doi: 10.1016/0014-4827(63)90077-6. [DOI] [PubMed] [Google Scholar]
  4. Blaxter M. L. Nemoglobins: divergent nematode globins. Parasitol Today. 1993 Oct;9(10):353–360. doi: 10.1016/0169-4758(93)90082-q. [DOI] [PubMed] [Google Scholar]
  5. Boray J. C. Experimental fascioliasis in Australia. Adv Parasitol. 1969;7:95–210. doi: 10.1016/s0065-308x(08)60435-2. [DOI] [PubMed] [Google Scholar]
  6. Carmona C., Dowd A. J., Smith A. M., Dalton J. P. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol Biochem Parasitol. 1993 Nov;62(1):9–17. doi: 10.1016/0166-6851(93)90172-t. [DOI] [PubMed] [Google Scholar]
  7. Carmona C., McGonigle S., Dowd A. J., Smith A. M., Coughlan S., McGowran E., Dalton J. P. A dipeptidylpeptidase secreted by Fasciola hepatica. Parasitology. 1994 Jul;109(Pt 1):113–118. doi: 10.1017/s0031182000077817. [DOI] [PubMed] [Google Scholar]
  8. Chapman C. B., Mitchell G. F. Proteolytic cleavage of immunoglobulin by enzymes released by Fasciola hepatica. Vet Parasitol. 1982 Nov;11(2-3):165–178. doi: 10.1016/0304-4017(82)90039-5. [DOI] [PubMed] [Google Scholar]
  9. Dalton J. P., Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Mol Biochem Parasitol. 1989 Jun 15;35(2):161–166. doi: 10.1016/0166-6851(89)90118-7. [DOI] [PubMed] [Google Scholar]
  10. Dowd A. J., Smith A. M., McGonigle S., Dalton J. P. Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica. Eur J Biochem. 1994 Jul 1;223(1):91–98. doi: 10.1111/j.1432-1033.1994.tb18969.x. [DOI] [PubMed] [Google Scholar]
  11. Halton D. W. Observations on the nutrition of digenetic trematodes. Parasitology. 1967 Nov;57(4):639–660. doi: 10.1017/s003118200007311x. [DOI] [PubMed] [Google Scholar]
  12. Haroun E. T., Hillyer G. V. Resistance to fascioliasis--a review. Vet Parasitol. 1986 Mar;20(1-3):63–93. doi: 10.1016/0304-4017(86)90093-2. [DOI] [PubMed] [Google Scholar]
  13. Hillyer G. V., Soler de Galanes M., Rodriguez-Perez J., Bjorland J., Silva de Lagrava M., Ramirez Guzman S., Bryan R. T. Use of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg. 1992 May;46(5):603–609. doi: 10.4269/ajtmh.1992.46.603. [DOI] [PubMed] [Google Scholar]
  14. MANSOUR T. E. Effect of serotonin on phenol oxidase from the liver fluke Fasciola hepatica and from other sources. Biochim Biophys Acta. 1958 Dec;30(3):492–500. doi: 10.1016/0006-3002(58)90094-5. [DOI] [PubMed] [Google Scholar]
  15. McGonigle S., Dalton J. P. Isolation of Fasciola hepatica haemoglobin. Parasitology. 1995 Aug;111(Pt 2):209–215. doi: 10.1017/s0031182000064969. [DOI] [PubMed] [Google Scholar]
  16. McKerrow J. H., Doenhoff M. J. Schistosome proteases. Parasitol Today. 1988 Dec;4(12):334–340. doi: 10.1016/0169-4758(88)90002-6. [DOI] [PubMed] [Google Scholar]
  17. Mitchell G. F., Tiu W. U., Garcia E. G. Infection characteristics of Schistosoma japonicum in mice and relevance to the assessment of schistosome vaccines. Adv Parasitol. 1991;30:167–200. doi: 10.1016/s0065-308x(08)60308-5. [DOI] [PubMed] [Google Scholar]
  18. Rapic D., Dzakula N., Sakar D., Richards R. J. Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle. Vet Rec. 1988 Jan 16;122(3):59–62. doi: 10.1136/vr.122.3.59. [DOI] [PubMed] [Google Scholar]
  19. Sexton J. L., Milner A. R., Panaccio M., Waddington J., Wijffels G., Chandler D., Thompson C., Wilson L., Spithill T. W., Mitchell G. F. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J Immunol. 1990 Dec 1;145(11):3905–3910. [PubMed] [Google Scholar]
  20. Sexton J. L., Wilce M. C., Colin T., Wijffels G. L., Salvatore L., Feil S., Parker M. W., Spithill T. W., Morrison C. A. Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen. J Immunol. 1994 Feb 15;152(4):1861–1872. [PubMed] [Google Scholar]
  21. Smith A. M., Carmona C., Dowd A. J., McGonigle S., Acosta D., Dalton J. P. Neutralization of the activity of a Fasciola hepatica cathepsin L proteinase by anti-cathepsin L antibodies. Parasite Immunol. 1994 Jun;16(6):325–328. doi: 10.1111/j.1365-3024.1994.tb00356.x. [DOI] [PubMed] [Google Scholar]
  22. Smith A. M., Dowd A. J., Heffernan M., Robertson C. D., Dalton J. P. Fasciola hepatica: a secreted cathepsin L-like proteinase cleaves host immunoglobulin. Int J Parasitol. 1993 Dec;23(8):977–983. doi: 10.1016/0020-7519(93)90117-h. [DOI] [PubMed] [Google Scholar]
  23. Smith A. M., Dowd A. J., McGonigle S., Keegan P. S., Brennan G., Trudgett A., Dalton J. P. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol Biochem Parasitol. 1993 Nov;62(1):1–8. doi: 10.1016/0166-6851(93)90171-s. [DOI] [PubMed] [Google Scholar]
  24. Tielens A. G., van den Heuvel J. M., van den Bergh S. G. Changes in energy metabolism of the juvenile Fasciola hepatica during its development in the liver parenchyma. Mol Biochem Parasitol. 1982 Nov;6(5):277–286. doi: 10.1016/0166-6851(82)90060-3. [DOI] [PubMed] [Google Scholar]
  25. Tielens A. G., van den Heuvel J. M., van den Bergh S. G. The energy metabolism of Fasciola hepatica during its development in the final host. Mol Biochem Parasitol. 1984 Nov;13(3):301–307. doi: 10.1016/0166-6851(84)90121-x. [DOI] [PubMed] [Google Scholar]
  26. Tielens A. G., van der Meer P., van den Bergh S. G. The aerobic energy metabolism of the juvenile Fasciola hepatica. Mol Biochem Parasitol. 1981 Aug;3(4):205–214. doi: 10.1016/0166-6851(81)90052-9. [DOI] [PubMed] [Google Scholar]
  27. Wijffels G. L., Salvatore L., Dosen M., Waddington J., Wilson L., Thompson C., Campbell N., Sexton J., Wicker J., Bowen F. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity. Exp Parasitol. 1994 Mar;78(2):132–148. doi: 10.1006/expr.1994.1014. [DOI] [PubMed] [Google Scholar]
  28. Xu C. B., Verwaerde C., Grzych J. M., Fontaine J., Capron A. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur J Immunol. 1991 Aug;21(8):1801–1807. doi: 10.1002/eji.1830210804. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES